Can we monitor cell therapy with MR imaging at clinical field strength after systemic injection?
Clément
Olivier
O
Department of Radiology, Hôpital Européen Georges Pompidou and Inserm U 494, School of Medicine Paris 5, Paris 75908, France.
D000818:Animals; D002465:Cell Movement; D003287:Contrast Media; D003911:Dextrans; D052203:Ferrosoferric Oxide; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007501:Iron; D008081:Liposomes; D008279:Magnetic Resonance Imaging / Q000379:methods*; D058185:Magnetite Nanoparticles; D051379:Mice; D010087:Oxides
D003287:Contrast Media; D003911:Dextrans; D008081:Liposomes; D058185:Magnetite Nanoparticles; D010087:Oxides; D007501:Iron; C065507:ferumoxides; D052203:Ferrosoferric Oxide